Plasmodium falciparum gametocyte surface protein Pfs230 Domain 1 (Pfs230D1)

Pfs230 is a 230 kDa protein expressed on the surface of Plasmodium falciparum gametocytes and gametes, playing a vital role in the parasite's sexual reproduction phase [1]. It belongs to the 6-Cys protein family and is essential for the fusion of male and female gametes within the mosquito midgut [2]. The N-terminal Domain 1 (Pfs230D1) is the most prominent target for transmission-blocking vaccines (TBVs) because it contains highly conserved epitopes recognized by potent transmission-blocking antibodies [3]. By inducing antibodies in the human host, these vaccines aim to prevent the development of the parasite in the mosquito after a blood meal, thereby interrupting malaria transmission [4]. Clinical candidates like Pfs230D1-EPA have demonstrated the ability to elicit functional antibodies that show high transmission-reducing activity in standard membrane feeding assays [5]. This target is unique because it does not protect the individual vaccinated but rather provides community-level protection by reducing the parasite reservoir [6]. Challenges in targeting Pfs230D1 include the need for high antibody titers and the requirement for effective adjuvants to overcome the protein's inherent low immunogenicity [7].

Other names

Pfs230230 kDa gamete surface proteinPF3D7_0209000Pfs230 Domain 16-Cys protein Pfs230

Induction of transmission-blocking antibodies that bind to the gamete surface and inhibit fertilization within the mosquito midgut.